Skip to content
★ Sign in to follow
PH

Pacific Health Care Organization Inc Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by KUBOTA TOM, was filed 28 Jun 2024.

Pacific Health Care Organization Inc: what insiders have been doing

Pacific Health Care Organization Inc belongs to the Healthcare & Pharma sector. Filings by its managers are published through SEC (Form 4). No insider at Pacific Health Care Organization Inc has published a filing in the past twelve months. The most recent one dates from 28 June 2024.

Over the whole record (from 2007), the tally stands at 168 purchases and no sales. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 6.7 m USD and net income of 1.4 m USD.

These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Insider Decl.
171
Thresholds
n/a
Buy Volume
€1M
168 ops. · all time
Sell Volume
n/a
n/a

Since the insiders bought

  • Filed 28 Jun 2024 · 863 days ago · €2,247
    -9.1%
    Entry US$0.88 · Close at T+365 US$0.80

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 989 of 26,911 companies
80.9
score / 100
Value
83
Quality
79
FCF yld9.5%
Earn yld12%
EV/EBITDA6.3x
ROE7.5%
Gross mgn·
Net mgn21%
Debt/EBITDA0.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

US$0.94
Analyst consensus
·
Income statement
RevenueUS$6.7M
EBITDAUS$1.9M29% margin
Net incomeUS$1.4M15.2% margin
Valuation
PER (trailing)11.8x
P/Book0.9x
Beta0.23
Balance sheet & cash
Market capUS$12M
Total debtUS$35.3k
Free Cash FlowUS$1.1M
Profitability & ownership
ROE7.5%
ROA4.2%
% insiders78.9%
% institutions0.0%
Last declaration on 28 June 2024
Declarations171 total
  • ▲
    CEO & PresidentExecutives
    2,400 USD28SEC
    2,500 shares@ US$0.960.4% of flowCommonSEC:0001185185-24-000665:1
    Canonical exit: 24 Sept 2024 (T+90)
  • ▲
    CEO & PresidentExecutives
    9,800 USD28SEC
    10,000 shares@ US$0.981.5% of flowCommonSEC:0001185185-24-000665:2
    Canonical exit: 24 Sept 2024 (T+90)
  • ▲
    CEO & PresidentExecutives
    2,474 USD28SEC
    2,499 shares@ US$0.990.4% of flowCommonSEC:0001185185-24-000665:3
    Canonical exit: 24 Sept 2024 (T+90)
  • ▲
    CEO & PresidentExecutives
    5,640 USD28SEC
    6,000 shares@ US$0.941.5% of flowCommonSEC:0001185185-24-000665:0
    Canonical exit: 24 Sept 2024 (T+90)
  • ▲
    CEO & PresidentExecutives
    3,915 USD28SEC
    4,500 shares@ US$0.870.6% of flowCommonSEC:0001185185-24-000652:1
    Canonical exit: 22 Sept 2024 (T+90)
  • ▲
    CEO & PresidentExecutives
    1,425 USD28SEC
    1,500 shares@ US$0.950.2% of flowCommonSEC:0001185185-24-000652:2
    Canonical exit: 22 Sept 2024 (T+90)
  • ▲
    CEO & PresidentExecutives
    203 USD28SEC
    270 shares@ US$0.750.1% of flowCommonSEC:0001185185-24-000652:0
    Canonical exit: 18 Sept 2024 (T+90)
  • ▲
    CEO & PresidentExecutives
    111 USD28SEC
    140 shares@ US$0.790.0% of flowCommonSEC:0001185185-24-000622:1
    Canonical exit: 4 Sept 2024 (T+90)
  • ▲
    CEO & PresidentExecutives
    13,164 USD28SEC
    15,860 shares@ US$0.833.5% of flowCommonSEC:0001185185-24-000622:0
    Canonical exit: 4 Sept 2024 (T+90)
  • ▲
    CEO & PresidentExecutives
    4,563 USD28SEC
    6,084 shares@ US$0.751.2% of flowCommonSEC:0001185185-24-000604:0
    Canonical exit: 29 Aug 2024 (T+90)
  • ▲
    CEO & PresidentExecutives
    3,552 USD28SEC
    4,800 shares@ US$0.740.5% of flowCommonSEC:0001185185-24-000597:1
    Canonical exit: 26 Aug 2024 (T+90)
  • ▲
    CEO & PresidentExecutives
    2,960 USD28SEC
    4,000 shares@ US$0.740.8% of flowCommonSEC:0001185185-24-000597:0
    Canonical exit: 22 Aug 2024 (T+90)
  • ▲
    CEO & PresidentExecutives
    71 USD28SEC
    100 shares@ US$0.710.0% of flowCommonSEC:0001185185-24-000584:0
    Canonical exit: 19 Aug 2024 (T+90)
  • ▲
    CEO & PresidentExecutives
    71 USD28SEC
    100 shares@ US$0.710.0% of flowCommonSEC:0001185185-24-000568:0
    Canonical exit: 14 Aug 2024 (T+90)
  • ▲
    CEO & PresidentExecutives
    44,000 USD29SEC
    55,000 shares@ US$0.8012.3% of flowCommonSEC:0001185185-23-001023:0
    Canonical exit: 31 Dec 2023 (T+90)
  • ▲
    CEO & PresidentExecutives
    4,250 USD28SEC
    5,000 shares@ US$0.850.7% of flowCommonSEC:0001185185-23-001017:1
    Canonical exit: 26 Dec 2023 (T+90)
  • ▲
    CEO & PresidentExecutives
    17,000 USD28SEC
    20,000 shares@ US$0.854.7% of flowCommonSEC:0001185185-23-001017:0
    Canonical exit: 25 Dec 2023 (T+90)
  • ▲
    CEO & PresidentExecutives
    328 USD28SEC
    400 shares@ US$0.820.1% of flowCommonSEC:0001185185-23-001004:0
    Canonical exit: 21 Dec 2023 (T+90)
  • ▲
    CEO & PresidentExecutives
    164 USD28SEC
    200 shares@ US$0.820.0% of flowCommonSEC:0001185185-23-000965:0
    Canonical exit: 11 Dec 2023 (T+90)
  • ▲
    CEO & PresidentExecutives
    44,319 USD29SEC
    54,047 shares@ US$0.8212.1% of flowCommonSEC:0001185185-23-000958:0
    Canonical exit: 10 Dec 2023 (T+90)
  • ▲
    CEO & PresidentExecutives
    51,850 USD29SEC
    61,000 shares@ US$0.8514.2% of flowCommonSEC:0001185185-23-000946:0
    Canonical exit: 6 Dec 2023 (T+90)
  • ▲
    CEO & PresidentExecutives
    27,900 USD29SEC
    31,000 shares@ US$0.907.5% of flowCommonSEC:0001185185-23-000930:0
    Canonical exit: 28 Nov 2023 (T+90)
  • ▲
    CEO & PresidentExecutives
    30,450 USD28SEC
    35,000 shares@ US$0.874.6% of flowCommonSEC:0001185185-23-000650:1
    Canonical exit: 18 Sept 2023 (T+90)
  • ▲
    CEO & PresidentExecutives
    1,800 USD28SEC
    2,000 shares@ US$0.900.5% of flowCommonSEC:0001185185-23-000650:0
    Canonical exit: 18 Sept 2023 (T+90)
  • ▲
    CEO & PresidentExecutives
    4,410 USD28SEC
    4,500 shares@ US$0.980.7% of flowCommonSEC:0001185185-23-000144:1
    Canonical exit: 17 May 2023 (T+90)

25 of 171 declarations

About Pacific Health Care Organization Inc

Pacific Health Care Organization, Inc. (PFHO) is a small U.S. healthcare-services company listed in the United States on the OTCQB market, not on NYSE or NASDAQ at present. For French-speaking investors, PFHO is best understood as a niche workers’ compensation cost-containment specialist focused on California employers and claims administrators. The company’s core value proposition is to help manage medical spend and administrative complexity in workers’ compensation cases. Its principal office is in Irvine, California, United States. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1138476/000118518525000193/pacifichco10k123124.htm?utm_source=openai))

PFHO’s corporate history dates back to 1970, when it was incorporated in Utah as Clear Air, Inc. The company adopted the name Pacific Health Care Organization, Inc. in January 2001, marking a strategic shift into healthcare cost containment. A key milestone followed in February 2001 with the acquisition of Medex Healthcare, Inc., a California company founded in 1994. Medex remains central to the group’s operating model and manages Health Care Organizations (HCOs) and Medical Provider Networks (MPNs) in California. PFHO later added MMC, which oversees bill review and utilization review, and MMM, which handles medical case management and employee advocate services. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001138476/000118518526000897/pfho10k123125.htm?utm_source=openai))

Read moreShow less

From a business-line perspective, PFHO is not a diversified healthcare provider; it is a specialized service company. Its principal offerings include HCO administration, MPN administration, medical bill review, utilization review, medical case management, and related workers’ compensation support services. This mix positions the company along the claims-management and cost-control chain rather than in direct patient care. The company also disclosed that it discontinued lien representation services in the third quarter of 2023 because demand was insufficient. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001138476/000118518526000897/pfho10k123125.htm?utm_source=openai))

Competitively, PFHO occupies a narrow but defensible niche. Its scale is modest, and its geographic footprint is concentrated mainly in California, which makes the business highly dependent on local workers’ compensation dynamics, provider relationships, and regulatory conditions. That concentration can support specialization, but it also creates customer concentration risk. In its 2023 filing, the company disclosed that a few major customers accounted for a meaningful share of sales, reinforcing the microcap profile and the importance of account retention. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1138476/000118518524000392/pacifichco20231231_10k.htm?utm_source=openai))

Recent developments show a still-operating, small-cap company rather than a high-growth story. PFHO’s SEC filings indicate continued activity through 2024 and 2025, and the company reported full-year 2025 revenue of $6.72 million versus $6.07 million in 2024, helped by growth in medical case management and utilization review. For investors following SEC Form 4 insider transactions, the name is also relevant because insider filing activity can be a useful sentiment signal in microcap equities, especially when trading liquidity is limited. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001138476/000118518526000897/pfho10k123125.htm?utm_source=openai))